Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea

Journal of Medical Virology

Volumn 83, Issue 7, 2011, Pages 1172-1177

  Kim, Hyoung Su ^a   Kim, Sung Jun ^a   Park, Hye Won ^a   Shin, Woon Geon ^a   Kim, Kyung Ho ^a   Lee, Jin Heon ^a   Kim, Hak Yang ^a   Jang, Myoung Kuk ^a  

^a Hallym University Medical Center   (South Korea)

Author keywords

Hepatitis B virus; Hepatitis D virus; Korea; Prevalence

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS DELTA ANTIGEN; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DELTA AGENT HEPATITIS; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS DELTA VIRUS; HUMAN; KOREA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; VIRUS CARRIER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHYLOGENY; PREVALENCE; REPUBLIC OF KOREA; YOUNG ADULT;

HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS;

EID: 79955927259     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22095     Document Type: Article

References (32)

1. Bruix J, Sherman M. 2005. Management of hepatocellular carcinoma. Hepatology 42: 1208-1236.
2. Choi JG, Kang CK, Park WC, Chung MK, Lee HJ, Choi SB, Kim CS. 1987. Prevalence of delta infection in HBsAg positive patients. Korean J Gastroenterol 19: 117-121.
3. Cross TJ, Rizzi P, Horner M, Jolly A, Hussain MJ, Smith HM, Vergani D, Harrison PM. 2008. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 80: 277-282.
4. Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW. 2000. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 46: 420-426.
5. Fattovich G, Bortolotti F, Donato F. 2008. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors. J Hepatol 48: 335-352.
6. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, Sagnelli E, Brunetto MR, Rizzetto M. 2000. Chronic hepatitis D: A vanishing Disease? An Italian multicenter study. Hepatology 32: 824-827.
7. Gaeta GB, Stroffolini T, Smedile A, Niro G, Mele A. 2007. Hepatitis delta in Europe: Vanishing or refreshing? Hepatology 46: 1312-1313.
8. Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H. 2009. Virological and clinical characteristics of delta hepatitis in Central Europe. J Viral Hepat 16: 883-894.
9. Hsu SC, Syu WJ, Sheen IJ, Liu HT, Jeng KS, Wu JC. 2002. Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications. Hepatology 35: 665-672.
10. Huo TI, Wu JC, Lai CR, Lu CL, Sheng WY, Lee SD. 1996. Comparison of clinico-pathological features in hepatitis B virus-associated hepatocellular carcinoma with or without hepatitis D virus superinfection. J Hepatol 25: 439-444.
11. Huo T, Wu JC, Hwang SJ, Lai CR, Lee PC, Tsay SH, Chang FY, Lee SD. 2000. Factors predictive of liver cirrhosis in patients with chronic hepatitis B: A multivariate analysis in a longitudinal study. Eur J Gastroenterol Hepatol 12: 687-693.
12. Jang MK, Lee JY, Lee JH, Kim YB, Kim HY, Lee MS, Park CK, Yoo JY. 2001. Seroepidemiology of HBV infection in South Korea, 1995 through 1999. Korean J Internal Med 16: 153-159.
13. Jung SH, Kim JM, Ahn HJ, Park MJ, Paik KH, Choi W, Kim J, Han CJ, Kim YC, Lee JO, Hong YJ, Park HY, Jeong HH, Yoon MY, Lee MJ, Lee KH. 2005. The prevalence and clinical characteristics of hepatitis-delta infection in Korea. Korean J Hepatol 11: 43-50.
14. Khan A, Kurbanov F, Tanaka Y, Elkady A, Sugiyama M, Dustov A, Mizokami M. 2008. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. J Med Virol 80: 268-276.
15. Kim KH, Jung JB, Kang JK, Park IS, Choi HJ, Song KS, Park CI, Jung WH. 1985. Prevalence of delta-antigen among chronic hepatitis B virus infected patients in Korea. Korean J Med 29: 30-36.
16. Kim CY, Byun JH, Lee KH, Kim W, Jung HC, Lee HS, Yoon YB, Song IS. 1989. Acute viral hepatitis non-A non-B and hepatitis D virus infection in Korean adults. Korean J Gastroenterol 21: 887-895.
17. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
18. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. 2004. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 126: 1024-1029.
19. Lok AS, McMahon BJ. 2007. Chronic hepatitis B. Hepatology 45: 507-539.
20. Niro GA, Smedile A, Andriulli A, Rizzetto M, Gerin JL, Casey JL. 1997. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology 25: 728-734.
21. Oyunsuren T, Kurbanov F, Tanaka Y, Elkady A, Sanduijav R, Khajidsuren O, Dagvadorj B, Mizokami M. 2006. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses. J Med Virol 78: 1688-1695.
22. Pascarella S, Negro F. 2011. Hepatitis D virus: An update. Liver Int 31: 7-21.
23. Rizzetto M, Canese MG, Arico S, Crivelli O, Trepo C, Bonino F, Verme G. 1977. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 18: 997-1003.
24. Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Yamashiro T, Maeshiro T, Kinjo F, Saito A, Zukeran H. 2001. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection. J Med Virol 65: 478-484.
25. Shih HH, Jeng KS, Syu WJ, Huang YH, Su CW, Peng WL, Sheen IJ, Wu JC. 2008. Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus. J Virol 82: 2250-2264.
26. Shih HH, Shih C, Wang HW, Su CW, Sheen IJ, Wu JC. 2010. Pro-205 of large hepatitis delta antigen and Pro-62 of major hepatitis B surface antigen influence the assembly of different genotypes of hepatitis D virus. J Gen Virol 91: 1004-1012.
27. Suh DJ. 1985. Delta infection in HBV carriers with chronic liver diseases in Korea. Korean J Med 29: 57-61.
28. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
29. Viana S, Parana R, Moreira RC, Compri AP, Macedo V. 2005. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg 73: 808-814.
30. Wedemeyer H, Manns MP. 2010. Epidemiology, pathogenesis and management of hepatitis D: Update and challenges ahead. Nat Rev Gastroenterol Hepatol 7: 31-40.
31. Wedemeyer H, Heidrich B, Manns MP. 2007. Hepatitis D virus infection-Not a vanishing disease in Europe! Hepatology 45: 1331-1332.
32. Wu JC, Chen TZ, Huang YS, Yen FS, Ting LT, Sheng WY, Tsay SH, Lee SD. 1995. Natural history of hepatitis D viral superinfection: Significance of viremia detected by polymerase chain reaction. Gastroenterology 108: 796-802.